ARTICLE | Company News
Epigenomics, Cathay Fortune deal
April 28, 2017 5:56 PM UTC
Cathay's Blitz F16-83 GmbH subsidiary will acquire molecular diagnostics company Epigenomics for €7.52 per share, or about €171 million ($185.6 million) in cash. The price is a 52% premium on Epigenomics' closing price of €4.95 on April 25.
Blitz F16-83 will change its name to Summit Hero Holding GmbH. Epigenomics' partner and largest shareholder BioChain Institute Inc. (Newark, Calif.) will own an indirect stake in Summit...
BCIQ Target Profiles